DexCom, Inc. (DXCM)
Company Info
| ISIN | US2521311074 |
|---|---|
| CUSIP | 252131107 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | $50.39B |
|---|---|
| EPS | $1.29 |
| PE Ratio | 101.33 |
| PEG Ratio | 2.53 |
| Revenue (TTM) | $3.62B |
| Gross Profit (TTM) | $1.88B |
| EBITDA (TTM) | $783.70M |
| Year Range | $74.75 - $142.00 |
| Target Price | $151.32 |
| Short % | 4.28% |
| Short Ratio | 4.32 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: DXCM vs. PODD, DXCM vs. TNDM, DXCM vs. RMD, DXCM vs. VRSK, DXCM vs. SF, DXCM vs. VYM, DXCM vs. VOO, DXCM vs. LLY, DXCM vs. XLV, DXCM vs. SCHD
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in DexCom, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
DexCom, Inc. had a return of 5.99% year-to-date (YTD) and 6.30% in the last 12 months. Over the past 10 years, DexCom, Inc. had an annualized return of 31.85%, outperforming the S&P 500 benchmark which had an annualized return of 10.42%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 5.99% | 5.05% |
| 1 month | -1.25% | -4.27% |
| 6 months | 52.89% | 18.82% |
| 1 year | 6.30% | 21.22% |
| 5 years (annualized) | 34.75% | 11.38% |
| 10 years (annualized) | 31.85% | 10.42% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.21% | -5.18% | 20.54% | |||||||||
| 2023 | -7.61% | -4.79% | 30.05% | 7.42% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
DexCom, Inc.(DXCM)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for DexCom, Inc. (DXCM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the DexCom, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the DexCom, Inc. was 94.61%, occurring on Nov 20, 2008. Recovery took 1185 trading sessions.
The current DexCom, Inc. drawdown is 19.22%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.61% | May 5, 2006 | 643 | Nov 20, 2008 | 1185 | Aug 8, 2013 | 1828 |
| -58.24% | Nov 18, 2021 | 145 | Jun 16, 2022 | — | — | — |
| -56.37% | Sep 18, 2015 | 531 | Oct 26, 2017 | 176 | Jul 11, 2018 | 707 |
| -39.59% | Mar 6, 2014 | 44 | May 7, 2014 | 129 | Nov 7, 2014 | 173 |
| -36.81% | Feb 21, 2020 | 19 | Mar 18, 2020 | 20 | Apr 16, 2020 | 39 |
Volatility
Volatility Chart
The current DexCom, Inc. volatility is 9.33%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |